Open AccessIGF-I Bioactivity Might Reflect Different Aspects of Quality of Life Than Total IGF-I in GH-Deficient Patients During GH Treatment
Author(s) -
Aimee J. Varewijck,
Steven W. J. Lamberts,
Sebastian Neggers,
Leo J. Hofland,
J. A. M. J. L. Janssen
Publication year - 2013
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2012-2901
Subject(s) - medicine , quality of life (healthcare) , endocrinology , hypopituitarism , nursing
No relationship has been found between improvement in quality of life (QOL) and total IGF-I during GH therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom